But the IRA also targets the types of drugs that most commonly treat cancer for price controls four years sooner than it does biologics. "Small-molecule" drugs are up for price caps nine years ...

In fact, small molecule drug discovery is entering a renaissance ... with different workflows, tools, and data types. For example, to improve target understanding, proteomics teams exploring new or ...

Small-molecule drugs from this era ... I envision there will be types of drugs that will look weird to us because they don’t look like what we’re expecting.” Zoë Waller, associate professor ...

Small-molecule drugs — for example ... experiments used a couple of molecular design techniques to create types of peptide molecules that can get into cells more easily. Most peptides have ...

targeting different types of cancer. Zentalis Pharmaceuticals (NASDAQ:ZNTL) is a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small-molecule ...

Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial), Service ...

Josh Gottheimer. Buried in the text of the IRA is a provision that gives different treatment to two types of medicines, small molecule drugs and biologics. Small-molecule drugs are the ones you ...

Researchers led by Université de Montréal pathology and cell-biology professor Marc Therrien have identified major structural changes that enable the BRAF protein to escape control and mimic its ...

“Our STAT6 program represents a significant advancement in the discovery of an oral inhibitor for type 2 inflammatory ... but have been intractable to small molecule discovery.